COVID-19 Vaccine Protects Sufferers of Inflammatory Bowel Disease
Newswise - COVID-19 vaccines taken by people with inflammatory bowel disease (IBD), which affects millions worldwide, safely and effectively protects them from the SARS-Cov-2 virus, a Rutgers study finds. The...
The analysis found the following:
- Vaccinated IBD patients showed high levels of antibody response, known as seroconversion, two weeks after the first vaccine, indicating a strong, positive response to the vaccine. The response was even higher after two doses, as compared with one dose.
- Vaccinated IBD patients did not experience a higher...
Assessment of coronavirus disease 2019 severity in hospitalized pediatric patients with atopic dermatitis: a case‒control study Mohta A, Ghiya BC, Mehta RD, Prasad V - Indian J Paediatr Dermatol
BRIEF COMMUNICATION Year : 2022 | Volume : 23 | Issue : 2 | Page : 123-125 Assessment of coronavirus disease 2019 severity in hospitalized pediatric patients with atopic dermatitis:...
Conclusion: Our study contributes to the ever-growing data suggesting that atopic diathesis is not a risk factor for acquiring COVID-19.
Role of Body Mass and Physical Activity in Autonomic Function Modulation on Post-COVID-19 Condition: An Observational Subanalysis of Fit-COVID Study
Source : https://www.mdpi.com/1660-4601/19/4/2457
The harmful effects of coronavirus disease 2019 (COVID-19) can reach the autonomic nervous system (ANS) and endothelial function. Therefore, the detrimental multiorgan effects of COVID-19 could be induced by deregulations...
Overweight/obese subjects in the post-COVID-19 group presented significantly lower parasympathetic activity and reduced global variability compared to non-obese in control group (p
- Elevated plasmin(ogen) is a common feature in people with underlying medical conditions, including hypertension, diabetes, cardiovascular disease, cerebrovascular disease, and chronic renal illness, who are susceptible to SARS-CoV-2 infection.
- Plasmin enhances the virulence and infectivity of SARS-CoV-2 virus by cleaving its spike...
Scientists Uncover Why Long COVID Can Cause Pain
Newswise - Philadelphia (April 4, 2022) - A new animal study has provided important insights into how COVID-19 SARS-CoV-2 the virus responsible for COVID-19 can lead to long-term pain. The...
“Our findings could potentially lead to new therapies for patients suffering from acute and long COVID, as well as other pain conditions,” said Serafini. “Our study also shows that SARS-CoV-2 causes long-term effects on the body in drastically new ways, further underscoring why people should try to avoid being infected.”